Patients with hidradenitis suppurativa (HS) may benefit from assessment of acne status and optimization of co-management strategies, a recent study found. Researchers conducted a cross-sectional analysis identifying adults with acne vulgaris (AV) among HS and non-HS patients using electronic health records data from a population-based sample of >55 million patients. They found:
- Prevalence of AV among adults with HS was 15.2% (7,315 /48,050), compared to 2.9% (497,360 /16,899,470) for adults without HS.
- Prevalence was greatest among HS patients who were female (5,870/35,790; 16.4%), aged 18-44 years (5,260/28,870; 18.2%), non-white (3,120/17,825; 17.5%), obese (5,430/35,135; 15.5%), and had polycystic ovary syndrome (PCOS) (685/2,385; 28.7%).
- HS patients had 4.51 times the odds of having AV compared to non-HS patients, and the higher likelihood of having AV persisted across all HS subgroups.
- The association between HS and AV was generally stronger for patients who were male, aged ≥65 years, non-whites, and obese.
Wertenteil S, Strunk A, Garg A. Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa. [Published online ahead of print October 1, 2018]. J Am Acad Dermatol. doi:10.1016/j.jaad.2018.09.040.
This Week's Must Reads
Must Reads in Acne
FDA Approves Seysara for Severe Acne Vulgaris, Paratek Pharmaceuticals, Inc. news release; 2018 Oct 2